Work

BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis

Year: 2020

Type: article

Source: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

DOI: 10.1016/j.bbadis.2020.166061

Authors: Kassandra Koumaki, Georgia Kontogianni, Vivian Kosmidou, Fani Pahitsa, Eftichia Kritsi, Maria Zervou, Aristotelis Chatziioannou, Vassilis L. Souliotis, Olga Papadodima, Alexander Pintzas

Institution: National Hellenic Research Foundation

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: European Commission, General Secretariat for Research and Technology, European Regional Development Fund

Awards: G108378697, G1337233005, G1888088267, G1953887145, G6167527624

OpenAlex ID: W3116399129

FWCI: 0.873

Cites: 63

Cited by: 37

Related to: 10